Equities
  • Price (EUR)107.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+7.00%
  • Beta--
Data delayed at least 15 minutes, as of Mar 27 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Globe Life Inc. is an insurance holding company. The Company's primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, and intensive care products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It has four segments: life insurance, supplemental health insurance, annuities and investments. Life insurance segment’s products include traditional whole life and term life insurance.

  • Revenue in USD (TTM)5.45bn
  • Net income in USD970.76m
  • Incorporated1979
  • Employees3.64k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GL:NYQ since
announced
Transaction
value
Evry Healthcare IncAnnounced13 Oct 202313 Oct 2023Announced2.85%--
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.